EP
MRNA icon

Eudaimonia Partners’s Moderna MRNA Stock Holding History

Eudaimonia Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1.67M Buy
4,349
+51
+1% +$18.8K 0.3% 94
2021
Q2 		$1.01M Buy
4,298
+629
+17% +$112K 0.19% 136
2021
Q1 		$480K Buy
3,669
+2,302
+168% +$334K 0.1% 195
2020
Q4 		$143K Buy
1,367
+669
+96% +$67.7K 0.03% 366
2020
Q3 		$49K Buy
+698
New +$48.7K 0.01% 566

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Eudaimonia Partners's MRNA Position: Q3 2021 in Review

Eudaimonia Partners increased its Moderna (MRNA) stake by 1.2% in Q3 2021, buying an estimated $18.8K and bringing the position to 4,349 shares worth $1.67M. The position accounts for 0.3% of the portfolio, ranked #94.

Eudaimonia Partners first reported a position in MRNA in Q3 2020 and has held it in 5 quarters since. 1,140 funds tracked by Wall St. Rank hold MRNA as of Q3 2021.

  • Eudaimonia Partners held 4,349 shares of Moderna worth $1.67M as of Q3 2021.
  • Eudaimonia Partners bought 51 Moderna shares in Q3 2021, an estimated $18.8K.
  • Moderna made up 0.3% of Eudaimonia Partners's portfolio in Q3 2021, its #94 holding.
  • Eudaimonia Partners first reported a position in Moderna in Q3 2020 and has held it in 5 quarters since.
  • 1,140 funds tracked by Wall St. Rank held Moderna as of Q3 2021.

Based on Eudaimonia Partners's 13F filing for Q3 2021, filed 25 Oct 2021.